Skip to main content

W22 Pill - white round, 10mm

Pill with imprint W22 is White, Round and has been identified as Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 8 mg (base) / 2 mg (base). It is supplied by Accord Healthcare Inc.

Buprenorphine/naloxone is used in the treatment of Opioid Use Disorder and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Buprenorphine/naloxone 8 mg (base) / 2 mg (base) is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Images for W22

Buprenorphine hydrochloride and naloxone hydrochloride (sublingual) 8 mg (base) / 2 mg (base) W22

Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual)

Imprint
W22
Strength
8 mg (base) / 2 mg (base)
Color
White
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Narcotic analgesic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
3 - Moderate abuse potential
Labeler / Supplier
Accord Healthcare Inc.
Manufacturer
WES Pharma Inc.
National Drug Code (NDC)
16729-0549

Get help with Imprint Code FAQs.

Related images for "W22"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.